Advancing Oncology: The Growing Impact of VEGFR-2 Inhibitors

added blog Health

2025-09-30 07:13:08

VEGFR-2 inhibitors have become a cornerstone in targeted cancer therapy, particularly for solid tumors. By blocking VEGFR-2 signaling, these drugs inhibit angiogenesis—the process of new blood vessel formation that nourishes tumors. The VEGFR-2 Inhibitor Market is expanding rapidly due to increasing demand, a robust pipeline of investigational agents, and growing global interest from...

0 Comments 0 Shares 627 Views 0 Reviews